About

Our origin

Our Founder and CEO, Vamsy Mojjada, conceived Q BRIDGE AI as a core entity within the Q BRIDGE Group — encompassing Q BRIDGE Data-Labs, Q BRIDGE Care, and DOT — to rectify clinical research inefficiencies through streamlined, accelerated, and cost-optimized processes with AI in healthcare.

As artificial intelligence integrated into operational frameworks, the vision matured into a singular, scalable platform spanning the R&D lifecycle. This yielded our name: Q BRIDGE AI — quantum-level datapoint bridging for AI healthcare. Registered in August 2025, this enterprise represents a deliberate strategic pivot at age 41, designed to deploy transformative solutions driving measurable global advancements in life sciences.

Interconnecting datapoints — from strategic conception to bridged equity in clinical trials.

Where we are today

All six solutions of the ecosystem are built, verified, and source-available — clinical trials, hospital operations, patient care, workforce, wellness, and quality management — each on the same audited security spine, each with a governed Claude assist running live.

Our Q BRIDGE AI story

The road, honestly marked

  • September 2025 · done

    Conceptualization

    Initiative to enhance clinical research efficiencies amid AI integration, evolving into a unified R&D architecture for AI in healthcare. Formal registration August 2025.

  • January 2026 · done

    Primary Deployment

    Strategic alignment and planning; datapoint architecture development and interconnection protocols for clinical trial AI.

  • June 2026 · done

    Six Solutions Shipped

    All six solutions built and verified — 24 of 24 increments — source-available, on the standardized security spine, with governed Claude assists live in every product.

  • Late 2026

    Global Infrastructure

    Hosted platform scale-out: managed deployments, regional data residency, and onboarding for research organizations and small companies at no cost.

  • Early 2027

    Enterprise Transformations

    Enterprise and government deployments — complimentary for strategic public-health partners — advancing universal access to quality care.